Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280997
Max Phase: Preclinical
Molecular Formula: C43H65N15O8S2
Molecular Weight: 984.22
Associated Items:
ID: ALA5280997
Max Phase: Preclinical
Molecular Formula: C43H65N15O8S2
Molecular Weight: 984.22
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H](NC(=O)c1cc2ccccc2cc1N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C43H65N15O8S2/c44-27-20-25-11-5-4-10-24(25)19-26(27)36(61)53-28(12-6-16-51-42(47)48)37(62)54-29(13-7-17-52-43(49)50)38(63)55-30(14-15-34(45)59)39(64)56-31(18-23-8-2-1-3-9-23)40(65)58-33-22-68-67-21-32(35(46)60)57-41(33)66/h4-5,10-11,19-20,23,28-33H,1-3,6-9,12-18,21-22,44H2,(H2,45,59)(H2,46,60)(H,53,61)(H,54,62)(H,55,63)(H,56,64)(H,57,66)(H,58,65)(H4,47,48,51)(H4,49,50,52)/t28-,29-,30+,31+,32+,33+/m1/s1
Standard InChI Key: LLJPMQGTLJIJPZ-LPQZNVNGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 984.22 | Molecular Weight (Monoisotopic): 983.4582 | AlogP: -1.41 | #Rotatable Bonds: 24 |
Polar Surface Area: 410.60 | Molecular Species: BASE | HBA: 13 | HBD: 15 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 20 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.77 | CX Basic pKa: 11.84 | CX LogP: -3.45 | CX LogD: -7.46 |
Aromatic Rings: 2 | Heavy Atoms: 68 | QED Weighted: 0.02 | Np Likeness Score: 0.12 |
1. Brust A, Croker DE, Colless B, Ragnarsson L, Andersson Å, Jain K, Garcia-Caraballo S, Castro J, Brierley SM, Alewood PF, Lewis RJ.. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties., 59 (6): [PMID:26859603] [10.1021/acs.jmedchem.5b00911] |
Source(1):